Related Experiment Video
Updated: May 15, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
A case-control study suggests that the CCR6 locus is not involved in the susceptibility to giant cell arteritis
A Serrano1, F D Carmona, S Castañeda
1Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain.
Objectives:
Polymorphisms of the CC chemokine receptor 6 (CCR6) gene have been recently reported to be associated with a number of autoimmune diseases. We aimed to investigate the possible influence of CCR6 rs3093024 gene variant in the susceptibility to and clinical expression of GCA.
Methods:
The CCR6 polymorphism rs3093024 was genotyped in a total of 463 Spanish patients diagnosed with biopsy-proven GCA and 920 healthy controls using a TaqMan® allelic discrimination assay. PLINK software was used for the statistical analyses.
Results:
No significant association between this CCR6 variant and GCA was observed (p=0.42, OR=0.94, CI95% 0.79-1.10). Similarly, when patients were stratified according to the specific clinical features of GCA such as polymyalgia rheumatica, visual ischaemic manifestations or irreversible occlusive disease, no statistical significant difference was detected either between the case subgroups and the control set or between GCA patients with and without the specific features of the disease.
Conclusions:
Our results suggest that the CCR6 rs3093024 polymorphism may not play a relevant role in the GCA pathophysiology.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The JAK-STAT Signaling Pathway

